YUMAB GmbH
PrivateLast Round
Grant
Jan 27, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
YUMAB GmbH operates in Healthcare & Life Sciences and is based in Braunschweig. It was founded in 2012.
YUMAB GmbH is a biotechnology company that provides contract research, technologies, and R&D services for the development of fully human therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YUMAB GmbH Comparables
Compare YUMAB GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isogenica | 83% | |
| Adimab | 78% | |
| Twist Bioscience Corporation | 77% |
For institutional investors. Book with your work email.
YUMAB GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 27, 2025 | ||||
| Grant | Oct 17, 2023 | ||||
| Grant | Jul 19, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
YUMAB GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| NBank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 313% MoM, from 204 to 842.
- Jul 29, 2026
Monthly visitors increased 325% MoM, reaching 204.
For institutional investors. Book with your work email.
YUMAB GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about YUMAB GmbH's valuation, stock price, and market status.
Is YUMAB GmbH a public or private company?
YUMAB GmbH is a private company.
What is the current stock price of YUMAB GmbH?
YUMAB GmbH is a private company, so its shares have no public market price. Caplight tracks YUMAB GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is YUMAB GmbH worth (valuation)?
Valuation information for YUMAB GmbH is not publicly available.
Can I buy YUMAB GmbH stock?
YUMAB GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was YUMAB GmbH's last funding round?
YUMAB GmbH's most recent funding round was Grant on January 27, 2025.
Who are the main investors in YUMAB GmbH?
Key investors in YUMAB GmbH include Bundesministerium für Bildung und Forschung, NBank.
Will YUMAB GmbH IPO soon?
No public IPO plans have been announced for YUMAB GmbH.
How can I track YUMAB GmbH secondary market activity?
Caplight tracks bids, offers, and trades in YUMAB GmbH's shares on secondary markets.